Sanofi
New data shows pharma has not cut back on controversial payments to physicians
July 6, 2017Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant
Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …
New potential blockbuster RA treatment enters European market
June 27, 2017Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi
The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …
Sanofi and Regeneron posts positive Praluent cholesterol data
June 12, 2017Research and Development, Sales and Marketing Regeneron, Sanofi, praluent
Sanofi and Regeneron were able to update its PCSK9 therapy Praluent with the positive data showing it could reduce levels …
NICE U-turns to recommend Sanofi Gaucher disease drug
June 2, 2017Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi
It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …
EMA’s CHMP recommends Sanofi’s Humalog biosimilar
May 22, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi
Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …
Sanofi Zika vaccine deal causes controversy
May 22, 2017Sales and Marketing Sanofi, US army, Zika
In a further twist to Sanofi’s deal with the US Army to develop a vaccine for the Zika virus, the …
Sanofi joins growing list of companies making pricing commitments
May 10, 2017Medical Communications, Research and Development Sanofi, pricing, transparency
Sanofi has entered an ever-growing list of pharmaceutical companies that are pledging to limit the levels of their price increases …
Sanofi launches lawsuit against Mylan over “illegal business practices”
April 26, 2017Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit
In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …
Sanofi to pay $20m fine for overcharging US veterans
April 4, 2017Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US
Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …
FDA approves first-ever atopic dermatitis biologic treatment
March 31, 2017Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic
Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …
Breakthrough eczema drug given FDA approval
March 29, 2017Research and Development, Sales and Marketing Dupixent, Regeneron, Sanofi
Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …
Sanofi looks to close $1 billion deal Flexion
March 24, 2017Medical Communications, Sales and Marketing Sanofi, flexion therapeutics, osteo
According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The …
Pakistan’s problem with diabetes – with 7 million diabetics
March 20, 2017Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes
Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …
Patients in UK to be given early access to Sanofi’s eczema treatment
March 14, 2017Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi
Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …
Sanofi and Lonza partner up for €270m biologics facility
February 28, 2017Manufacturing and Production Lonza, Sanofi
Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …
Latest content
Five Facts about cardiovascular disease
